Keyphrases
Transforming Growth Factor-β
100%
Transforming Growth Factor-β Signaling
100%
Prostate Cancer
100%
Prostate Cancer Cells
50%
Metastasis
25%
Non-coding RNA (ncRNA)
25%
Genetic Modification
12%
Epigenetic Modification
12%
Valproic Acid
12%
Prostate Cancer Patients
12%
Proliferation Response
12%
Abnormal Expression
12%
Thymoquinone
12%
Recurrent Prostate Cancer
12%
Clinical Application
12%
Therapy Response
12%
Pathological Conditions
12%
Prostatectomy
12%
Pharmacological Compounds
12%
Cytotoxic T Cells
12%
Secreted Cytokine
12%
Immune Evasion
12%
Regulatory T Cells
12%
Prostate Cancer Development
12%
Prostate Radiotherapy
12%
Antitumor Activity
12%
Overexpression
12%
Leading Causes of Death
12%
MicroRNA
12%
Poor Prognosis
12%
Medicine and Dentistry
Prostate Cancer
100%
Mediator
100%
Transforming Growth Factor Beta
100%
Cancer Cell
28%
Metastatic Carcinoma
14%
Cancer Therapy
7%
Malignant Neoplasm
7%
Cytokine
7%
Recurrent Disease
7%
Untranslated RNA
7%
Cytotoxic T-Cell
7%
Antineoplastic Activity
7%
Prostatectomy
7%
Treatment Response
7%
Regulatory T Cell
7%
Biological Functions
7%
microRNA
7%
Thymoquinone
7%
Epithelial Mesenchymal Transition
7%
Upregulation
7%
Immune Evasion
7%
Drug Resistance
7%
Sodium Valproate
7%
Biochemistry, Genetics and Molecular Biology
Transforming Growth Factor Beta
100%
Mediator
100%
Cancer Cell
28%
MicroRNA
7%
Epigenetics
7%
Genetics
7%
Non-Coding RNA
7%
Biological Functions
7%
Regulatory T Cell
7%
Cytotoxic T Cell
7%
Drug Resistance
7%
Upregulation
7%
Cytokine
7%
Antineoplastic Activity
7%
Immune Evasion
7%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Transforming Growth Factor Beta
100%
Malignant Neoplasm
7%
Cytokine
7%
Neoplasm
7%
Drug Resistance
7%
Recurrent Disease
7%
Untranslated RNA
7%
microRNA
7%
Sodium Valproate
7%
Thymoquinone
7%